Latest Development Pipeline News

Page 5 of 32
Dexus Convenience Retail REIT has reported solid half-year results for 2026, underpinned by resilient income growth and a $19.8 million uplift in portfolio valuation. The fund maintains a conservative capital structure while advancing key development projects.
Eva Park
Eva Park
9 Feb 2026
Dexus Convenience Retail REIT (DXC) reports solid HY26 results with strong income growth and high occupancy, while advancing strategic development projects to enhance its metro and highway retail footprint.
Eva Park
Eva Park
9 Feb 2026
Dexus Convenience Retail REIT has reported a striking 143.8% increase in net profit for the half-year to December 2025, underpinned by strong portfolio occupancy and rising property valuations. The REIT reaffirmed its FY26 guidance, signalling confidence in its defensive income strategy and development pipeline.
Eva Park
Eva Park
9 Feb 2026
HMC Capital has forged a strategic partnership with global investor KKR, securing up to $603 million to expand its Energy Transition Platform focused on battery storage and wind projects. This deal aims to boost Australia’s renewable capacity while enhancing shareholder returns.
Maxwell Dee
Maxwell Dee
6 Feb 2026
Great Divide Mining has raised $2.5 million through a share placement to fund development at its Challenger Gold Mine and progress other key projects.
Maxwell Dee
Maxwell Dee
5 Feb 2026
Everlast Minerals has secured a significant new exploration licence in northern Bangladesh, boosting its mineral sands portfolio and advancing its development strategy.
Maxwell Dee
Maxwell Dee
5 Feb 2026
Delorean Corporation has completed the $53 million Yarra Valley Water bioenergy facility and progressed key projects in South Australia and Victoria, supported by strong government grants and renewable gas policies.
Victor Sage
Victor Sage
30 Jan 2026
Biotron Limited has successfully closed its fully subscribed rights issue, raising $1.52 million, and completed the acquisition of Sedarex Limited, positioning itself for growth in its diversified biotech portfolio.
Ada Torres
Ada Torres
30 Jan 2026
Noxopharm has successfully completed dosing in its HERACLES clinical trial for SOF-SKN™, demonstrating strong safety and tolerability. The company also secured a new overseas partnership and its first US patent for the Sofra platform.
Ada Torres
Ada Torres
30 Jan 2026
Patrys Limited has expanded its therapeutic portfolio by acquiring Reliis Pty Ltd, adding a proprietary injectable asset targeting delirium with near-term clinical milestones. This strategic move complements its existing biologics platform and strengthens its financial position.
Ada Torres
Ada Torres
30 Jan 2026
Lunnon Metals has secured unconditional status for its Ore Purchase Agreement with Gold Fields and approved mining at Lady Herial, backed by a robust feasibility study projecting strong cash flows. Exploration continues aggressively across its gold and nickel projects in Western Australia.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Micro-X Ltd has secured a historic $3.3 million order for its Rover mobile X-ray units in Malaysia, alongside a $6.2 million capital raise to fuel its expanding medical imaging and security technology pipeline.
Victor Sage
Victor Sage
30 Jan 2026